Results 1 to 10 of about 6,403 (186)
Application of fractional exhaled nitric oxide and nasal nitric oxide in the evaluation of asthma control [PDF]
Frontiers in Pediatrics, 2023 BackgroundAsthma is the most common chronic respiratory disease in childhood, and effective control of airway inflammation is crucial in its management.
Yucong Ma +5 more
doaj +4 more sources
The Relationship of Fractional Exhaled Nitric Oxide in Patients with AECOPD [PDF]
International Journal of COPD, 2023 Xiaoguang Xu,1,2 Lefei Zhou,3 Zhaohui Tong1 1Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing, People’s Republic of China; 2Department of ...
Xu X, Zhou L, Tong Z
doaj +4 more sources
Measurements of fractional exhaled nitric oxide in pediatric asthma [PDF]
Korean Journal of Pediatrics, 2013 Exhaled nitric oxide (NO) has been extensively investigated as a noninvasive marker of airway inflammation in asthma. The increased NO expression induced by inflammatory mediators in airways can be monitored easily in exhaled air from asthmatic children.
Youn-Soo Hahn
doaj +3 more sources
Fractional Exhaled Nitric Oxide in Eosinophilic COPD. [PDF]
Chronic Obstr Pulm DisEosinophilic chronic obstructive pulmonary disease (COPD) is a distinct subtype with clinical and biological differences from noneosinophilic COPD and asthma. Fractional exhaled nitric oxide (FeNO) is an established marker of type 2 airway inflammation in asthma, but its utility in eosinophilic COPD is less well understood.
Morejon-Jaramillo PE +10 more
europepmc +4 more sources
An Overview of Fractional Exhaled Nitric Oxide and Children with Asthma [PDF]
Expert Review of Clinical Immunology, 2016 Asthma is the most common pediatric chronic disease and is characterized by lung inflammation. Fractional exhaled nitric oxide (FeNO) is thought to reflect the presence of eosinophilic airway inflammation, and is an easy, non-invasive test that has held promise in providing additional objective data.
Wanda Phipatanakul
exaly +3 more sources
Fractional Exhaled Nitric Oxide (FeNo) in Different Asthma Phenotypes
Allergy & Rhinology, 2014 Fractioned exhaled nitric oxide (FeNO) is a noninvasive marker of inflammation in asthmatic patients. FeNO can be used to monitor airway inflammation, but individual responses make tailored interventions based on FeNO difficult.
Bilun Gemicioglu M.D. Ph.D. +3 more
doaj +3 more sources
Fractional exhaled nitric oxide-measuring devices: technology update
Medical Devices: Evidence and Research, 2016 Mauro Maniscalco,1 Carolina Vitale,2 Alessandro Vatrella,2 Antonio Molino,3 Andrea Bianco,4 Gennaro Mazzarella4 1Unit of Respiratory Diseases, Hospital “S Maria della Pietà” of Casoria, Naples, 2Unit of Respiratory Medicine, Department
Maniscalco M +5 more
doaj +7 more sources
An assessment of fractional exhaled nitric oxide inchildren with allergic rhinitis
Pediatria i Medycyna Rodzinna, 2016 Allergic rhinitis is an inflammatory condition of the nasal mucosa usually elicited by IgE-mediated response to allergen exposure. It is currently considered the most common allergic disease.
Ewa Dadas-Stasiak +3 more
doaj +2 more sources
Fractional Exhaled Nitric Oxide in Teenagers and Adults with Atopic Dermatitis. [PDF]
Adv Respir Med, 2022 Fractional exhaled nitric oxide (FeNO) is a non-invasive biomarker of eosinophilic airway inflammation and therapeutic response to corticosteroid treatment of respiratory diseases. Atopic dermatitis (AD), one of the most common allergic conditions of the skin, is a factor influencing the increase of FeNO.
Galiniak S, Rachel M.
europepmc +3 more sources
Role of Fractional Exhaled Nitric Oxide for Monitoring Bronchial Asthma
Journal of Nepal Health Research CouncilBackground: Monitoring during treatment of asthma is usually done by various clinical tools, spirometry, sputum eosinophils and fractional exhaled nitric oxide.
Buddhi Sagar Lamichhane +4 more
doaj +3 more sources